ABSTRACT -The objective of this study was to evaluate the efficiency of cyclic and acyclic progesterone-treated recipient mares in a commercial embryo transfer program. Acyclic recipients were treated with decreasing amounts of estradiol cypionate (ECP ® -Pfizer Saúde Animal, São Paulo, Brazil), followed by 1500 mg of a sustained-release progesterone injection (P4LA150 ® -Laboratórios B.E.T., Rio de Janeiro, Brazil). Out of all 1506 embryo recovery attempts performed, 59.36%
Introduction
In Brazil, equine embryo transfer has been facing growing interest since the first national studies were published (Fleury et al., 1987; Henry et al., 1987) . Nowadays, Brazil is one of the main countries in number of annual successful transfers (Losinno & Alvarenga, 2006) . It is known that success rates after an embryo transfer procedure are affected by many factors such as those related to donors and recipients, semen used, embryo quality, manipulation and storage, transfer technique and climatic conditions (Squires et al., 1999; Carnevale et al., 2000) .
In order to obtain satisfactory results, it is essential that progesterone act on the reproductive tract of recipient mares (Mckinnon et al., 1988a; Fleury, 2002) . Progesterone is the only ovarian hormone necessary to maintain an early pregnancy in the equine species (Wilker et al., 1991; Goff, 2002) . Ovariectomized or acyclic mares under hormonal treatment can be successfully used as embryo recipients (Hinrichs et al., 1985; Carnevale et al. 2000; Riera et al., 2008) . The use of recipients either in anestrous or transition allows embryo transfer programs to start earlier and finish a couple months later, for the period recipients show cyclic activity is short, compared with donors. In this matter, the use of progesterone-treated acyclic mares reduces the need for ovulation synchronization between donors and recipients, requiring less frequent reproductive evaluations (Rocha Filho et al., 2004) .
In Brazil, treatment of acyclic recipients with longacting progesterone has been routinely conducted in commercial equine embryo transfer programs. However, more studies focusing the major obstacles to its success are necessary: low post-transfer pregnancy rates and high embryo mortality rates.
The present study aimed to evaluate the efficiency of a commercial equine embryo transfer program using cyclic and long-acting progesterone-treated acyclic recipients. The authors assumed that long-acting progesterone-treated acyclic and cyclic recipients have similar pregnancy and embryo mortality rates and that the interval between the onset of long-acting progesterone treatment and embryo transfer does not affect either pregnancy or embryo mortality rates.
Material and Methods
This study was conducted in a commercial equine embryo transfer clinic, Clínica Equus Veterinária, located in Itaboraí city, Rio de Janeiro State, Brazil (latitude 22º44' 40" S; longitude 42º 51' 34" O and 46 meters of altitude). Data concerning reproductive activities between July 2005 and March 2008 were recorded. Campolina breed stallions, donors (average 14.8±3.1 of age) and recipients were resident at the clinic. Throughout this period, animals were submitted to constant management conditions. Embryo recovery, handling and transfer, as well as recipient selection, were performed by the same veterinarian.
Donor mares were daily evaluated through rectal palpation and ultrassonography (Aloka ® SSD-500, Aloka Co., Japan), beginning four days after an embryo recovery attempt. Reproductive characteristics such as follicle diameter, uterine tone and grade of endometrial edema were monitored.
Donor mares showing follicles ≥35 milimeters (mm) were either artificially inseminated in alternate days until an ovulation occurred or treated with a single endovenous injection containing 2000 international units (IU) of human chorionic gonadotrophin (hCG, Vetecor 5000 ® -Hertape Calier Saúde Animal, Juatuba, MG, Brazil) and artificially bred until six hours post-ovulation. hCG was used to reduce the number of inseminations and to synchronize ovulations between donors and recipients.
Mares were artificially bred with either fresh or cooled semen, with at least 500 million progressively motile spermatozoa, placed at their uterine body. Upon detection of intrauterine fluid 48 hours post-insemination, donors were flushed with two or more liters of lactated ringers solution and intramuscularly injected with 2.5 mg/kg of enrofloxacin (Flotril ® -Schering-Plough, Cotia, SP, Brazil) and 20 IU of oxytocin (Placentina ® -U.C.B. Saúde Animal, Jaboticabal, SP, Brazil). Donors were once more evaluated 24 hours after their first ovulation, in order to detect multiple synchronic ovulations.
On the eight day post-ovulation, embryos were recovered using the method described by Squires et al. (1999) . At the end of the embryo recovery uterine flush, mares were intramuscularly injected with 10 miligrams (mg) of dinoprost tromethamine (Lutalyse ® -Pfizer Saúde Animal, São Paulo, SP, Brazil).
Using a binocular stereo microscope (Nikon ® SMZ 645, Nikon Co., Japan), embryos were identified, drawn into a 0.5-mL sterile semen straw and placed on a sterile Petri dish containing nine droplets of embryo holding solution (Emcare ® -ICP, Auckland, New Zeland). Embryos were washed by clockwise transfer through these droplets. A new 0.5-mL sterile semen straw was used every three transfers. Embryos were classified according to McKinnon & Squires (1988b) (Table 1) .
Follicular development and reproductive characteristics were monitored in recipient mares as previously described for donors. Estrous recipients were daily evaluated until an ovulation occurred, and, when necessary, 2000 IU of hCG were injected to induce ovulation and obtain synchronization with donors.
Recipients were considered as in anestrous or transition when, after three ultrassonographic evaluations, follicles under development would persist and/or regress, in the absence of a corpus luteum. Acyclic mares were intramuscularly treated with estradiol cypionate (ECP ® -Pfizer Saúde Animal, São Paulo, SP, Brazil) during three consecutive days, using decreasing doses of, respectively, 10 mg, 6 mg and 4 mg. If these mares showed endometrial edema development as a result of this estrogen treatment, 1500 mg of long-acting progesterone (P4LA150 ® -Laboratórios B.E.T., Rio de Janeiro, RJ, Brazil) were intramuscularly injected on the fourth day. Embryos were transferred to this group of mares, predominantly, during the first months of the breeding season. In order to evaluate the grade of uterine edema following estradiol cypionate treatment, uterine ecotexture was classified as proposed by De La Côrte et al. (1992) . Mares showing strong edema and clearly defined endometrial folds throughout the whole uterus were considered suitable for long-acting progesterone treatment.
After being successfully washed, embryos were drawn into sterile artificial insemination pipettes and transferred Table 1 -Classification system used to grade quality of equine embryos using the nonsurgical transcervical method, as proposed by Riera et al. (1993) . In this study, only fresh Grade I embryos, between six and eight days of age, were transferred. Recipients that did not become pregnant after the fifth inovulation were discarded. Cyclic recipients received embryos between the third and ninth day post-ovulation. Embryos were transferred to acyclic recipients between the third (P3) and sixth (P6) day after the first long-acting progesterone injection (P0). Acyclic mares were once more treated with 1.500 mg of long-acting progesterone at embryo transfer. Recipients were diagnosed as pregnant through ultrassonography, when embryos reached at least twelve days of age. Pregnant recipients were monitored every seven days, in order to detect possible embryonic losses. Acyclic pregnant mares received weekly injections containing 1500 mg of long-acting progesterone until 100 days of pregnancy.
Statistical analysis was performed using InStat 3 program. The following parameters were evaluated: pregnancy rates after embryo transfer and embryo mortality rates of cyclic and acyclic recipients. Likewise, the present study evaluated, on acyclic recipients, the influence of the interval between the onset of long-acting progesterone treatment and embryo transfer on pregnancy and embryo mortality rates. These dichotomous qualitative variables were compared in contingency tables and analyzed using the Chi-square test (χ 2 ). Significance levels were set as P<0.05.
Results and Discussion
From all 1506 performed embryo recovery attempts (Table 2) , 59.36% were positive (894/1506). A total of 1134 embryos were obtained, leading to a 75.30% (1134/1506) embryo recovery rate.
The percentage of positive flushes in the present study (59.36%) is similar to the ones reported using fresh and cooled semen (Squires et al., 2003) . The age of resident donors at the clinic, which averaged 14.8 years at certain periods, can be accounted for reducing this rate. According to previously published studies, older mares show lower embryo recovery rates (Ball et al., 1989; Squires et al., 2003) .
Out of all 1134 embryos recovered, 964 were classified as of Grade I. Upon transfer, 458 recipients became pregnant (47.51%; 458/964). Two hundred forty-one embryos were transferred to acyclic and 723 to cyclic recipients, resulting in pregnancy rates of, respectively, 57.68% (139/241) and 44.12% (319/723). Acyclic mares treated with long-acting progesterone showed higher pregnancy rates (P<0.0003) than cyclic mares. On the other hand, similar embryo mortality rates (P>0.05) were observed in acyclic (11.51% -16/139) and cyclic recipients (9.72% -31/319) ( Table 3) .
In the present study, the pregnancy rate obtained (47.51%) was lower than the ones reported using nonsurgical transcervical embryo transfer, such as 70% (Squires et al., 1999) , 82.9% (Foss et al., 1999 ), 65.7% (Carnevale et al., 2000 , 74.9% (Fleury et al., 2001 ) and 82.5% (Jasko, 2002) . It is known that the proper management of recipients is the major factor for success in embryo transfer programs (Squires et al., 1999; Losinno & Alvarenga, 2006) . The low recipient:donor ratio in this study might have been responsible for the unsatisfactory pregnancy rates obtained, making recipient selection harder. According to Carnevale et al. (2000) and Alonso et al. (2008) , proper selection of recipients dramatically influences pregnancy rates.
In the present study, acyclic recipients under progesterone treatment showed higher pregnancy rates than cyclic ones (44.12% versus 57.68%, respectively). In previously published studies, acyclic recipients presented either similar (Carnevale et al., 2000; Rocha Filho et al., 2004) or lower pregnancy rates (Riera et al., 2008) .
Upon evaluation of a commercial embryo transfer program in Argentina, Riera et al. (2008) found that progesterone-treated acyclic recipients showed satisfactory pregnancy rates, even though they were lower than the one obtained using cyclic mares (58% versus 74%). In their study, however, embryo transfer to recipients under hormonal treatment was conducted during the last months of the breeding season. It is possible that, at that time, less suitable recipients were available and, therefore, selected for embryo transfer.
To our knowledge, the results obtained in the present study, in which acyclic mares showed higher pregnancy rates after embryo transfer, have not yet been reported in the literature. Some hypothesis may justify this finding. The hormonal treatment of acyclic recipients allows that a superior number of mares be suitable for embryo transfer, improving selection and increasing success rates. Also, some cyclic recipients might suffer from premature luteolysis during transcervical embryo transfer, due to cervical manipulation. Kask et al. (1997) found that transcervical embryo transfer procedures can reduce plasmatic progesterone concentrations. Similar reductions have been detected by Handler et al. (2003) , when diestrous mares were submitted to cervical dilatation. More recently, McCue et al. (2008) observed the occurrence of complete luteolysis in 6.2% of the mares submitted to transcervical embryo transfer. On the other hand, plasmatic progesterone concentrations of acyclic recipients are not influenced by cervical manipulation, since they are dependent on an exogenous source. Embryo mortality rates of cyclic (9.72%) and acyclic (11.51%) recipients were similar to those obtained by Imel et al. (1981) , of 13%. Similar embryo mortality rates between cyclic and acyclic recipient mares had been previously observed by Rocha Filho et al. (2004) . Carnevale et al. (2000) identified that acyclic recipients under progestin treatment suffered from higher embryo mortality rates (30% versus 14.5%), which, however, did not differ statistically. During the latter, mares were not treated with estrogen prior to progestin administration. Further studies are necessary to determine whether pre-treatment with estrogen influences pregnancy and embryo mortality rates of acyclic mares.
Acyclic recipients on P3, P4, P5 and P6 showed similar (P>0.05) pregnancy rates at 12 days: 51.28% (20/39); 58.93% (33/56); 60.53% (46/76) and 58.57% (41/70), respectively. The interval between the onset of longacting progesterone treatment and embryo transfer did not affect pregnancy rates in acyclic recipient mares. Acyclic recipients on P3, P4, P5 and P6 showed embryo mortality rates (Table 4 ) of 20.00% (4/20), 12.12% (4/33), 2.17% (1/46) and 17.07% (7/41), respectively. Recipients on P3, P4 and P6 showed similar embryo mortality rates (P>0.05). However, pregnant recipients submitted to an embryo transfer procedure on P5 showed lower (P<0.02) embryo mortality rates than P3 and P6. Moreover, P4 recipients tended to suffer higher embryo mortality rates than P5 (P = 0.07).
In their study, Rocha Filho et al. (2004) Table 4 -Pregnancy and embryo mortality rates of acyclic recipients, according to the interval (in days) between the onset of progesterone treatment (P0) and embryo transfer
Conclusions
Acyclic recipients under long-acting progesterone treatment can be used in equine embryo transfer programs with higher pregnancy and similar embryo mortality rates, when compared with cyclic recipients. Long-acting progesteronetreated acyclic recipients can be used from the third to the sixth day post-injection, with similar pregnancy rates.
